William Winston

Person

Marlborough, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Activatable cytokine polypeptides and methods of use thereof
- Patent number 12,076,371
- Issue date Sep 3, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable cytokine polypeptides and methods of use thereof
- Patent number 12,036,266
- Issue date Jul 16, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,981,716
- Issue date May 14, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Separation moieties and methods of use thereof
- Patent number 11,739,132
- Issue date Aug 29, 2023
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-GDF-15 antibodies
- Patent number 11,725,047
- Issue date Aug 15, 2023
- AVEO Pharmaceuticals, Inc.
- Lorena Lerner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ErbB3 antibodies
- Patent number 11,680,108
- Issue date Jun 20, 2023
- AVEO Pharmaceuticals, Inc.
- Sylvie Vincent
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of uses thereof
- Patent number 11,590,224
- Issue date Feb 28, 2023
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,535,658
- Issue date Dec 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin 12 polypeptides and methods of use thereof
- Patent number 11,453,710
- Issue date Sep 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of use thereof
- Patent number 11,453,720
- Issue date Sep 27, 2022
- Potenza Therapeutics, Inc.
- Nels P. Nielson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,352,403
- Issue date Jun 7, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-neuropilin antigen-binding proteins and methods of use thereof
- Patent number 11,186,644
- Issue date Nov 30, 2021
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-Notch3 antibody
- Patent number 11,142,573
- Issue date Oct 12, 2021
- AVEO PHARMACEUTICALS, INC.
- Heidi Okamura
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-GITR antigen-binding proteins and methods of use thereof
- Patent number 10,988,545
- Issue date Apr 27, 2021
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-NOTCH3 antibodies
- Patent number 10,745,476
- Issue date Aug 18, 2020
- AVEO Pharmaceuticals, Inc.
- Heidi Okamura
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides
- Patent number 10,696,724
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable interleukin 12 polypeptides
- Patent number 10,696,723
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-GDF15 antibodies
- Patent number 10,597,444
- Issue date Mar 24, 2020
- AVEO Pharmaceuticals, Inc.
- Lorena Lerner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of use thereof
- Patent number 10,507,244
- Issue date Dec 17, 2019
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ERBB3 antibodies
- Patent number 10,494,441
- Issue date Dec 3, 2019
- AVEO Pharmaceuticals, Inc.
- Sylvie Vincent
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunomodulatory oncolytic adenoviral vectors, and methods of produ...
- Patent number 10,232,053
- Issue date Mar 19, 2019
- Trieza Therapeutics, Inc.
- Daniel Hicklin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-neuropilin antigen-binding proteins and methods of use thereof
- Patent number 10,227,413
- Issue date Mar 12, 2019
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-Notch3 antibodies
- Patent number 9,879,083
- Issue date Jan 30, 2018
- AVEO Pharmaceuticals, Inc.
- Heidi Okamura
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treatment using anti-GDF15 antibodies
- Patent number 9,725,505
- Issue date Aug 8, 2017
- AVEO Pharmaceuticals, Inc.
- Lorena Lerner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of use thereof
- Patent number 9,713,641
- Issue date Jul 25, 2017
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ErbB3 antibodies
- Patent number 9,598,498
- Issue date Mar 21, 2017
- AVEO Pharmaceuticals, Inc.
- Sylvie Vincent
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ErbB3 antibodies
- Patent number 9,228,021
- Issue date Jan 5, 2016
- AVEO Pharmaceuticals, Inc.
- Sylvie Vincent
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-GDF15 antibodies
- Patent number 9,175,076
- Issue date Nov 3, 2015
- AVEO Pharmaceuticals, Inc.
- Lorena Lerner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid encoding hepatocyte growth factor (HGF) binding proteins
- Patent number 9,096,664
- Issue date Aug 4, 2015
- AVEO Pharmaceuticals, Inc.
- William M. Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ron antibodies
- Patent number 8,829,164
- Issue date Sep 9, 2014
- AVEO Pharmaceuticals, Inc.
- Kerry Whalen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240358796
- Publication date Oct 31, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240262880
- Publication date Aug 8, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDUCIBLE IL-2 AND PD-1/PD-L1 COMBINATION THERAPY
- Publication number 20240216470
- Publication date Jul 4, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCIBLE CYTOKINE PRODRUG AND PD-1/PD-L1 COMBINATION THERAPY
- Publication number 20240216505
- Publication date Jul 4, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERFERON POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240216474
- Publication date Jul 4, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240174725
- Publication date May 30, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-GDF-15 ANTIBODIES
- Publication number 20240166734
- Publication date May 23, 2024
- AVEO PHARMACEUTICALS, INC.
- Lorena Lerner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE IL-12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240043488
- Publication date Feb 8, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Activatable Cytokine Polypeptides and Methods of Use Thereof
- Publication number 20240033326
- Publication date Feb 1, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230374093
- Publication date Nov 23, 2023
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ERBB3 ANTIBODIES
- Publication number 20230365710
- Publication date Nov 16, 2023
- AVEO PHARMACEUTICALS, INC.
- Sylvie Vincent
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20230272028
- Publication date Aug 31, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES TARGETING HSP70 AND THERAPEUTIC USES THEREOF
- Publication number 20230128075
- Publication date Apr 27, 2023
- Board of Regents, The University of Texas System
- Robert Z. ORLOWSKI
- G01 - MEASURING TESTING
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230056051
- Publication date Feb 23, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230051423
- Publication date Feb 16, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220324930
- Publication date Oct 13, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-NOTCH3 ANTIBODY
- Publication number 20220235127
- Publication date Jul 28, 2022
- AVEO Pharmaceuticals, Inc.
- Heidi Okamura
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20220220181
- Publication date Jul 14, 2022
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NEUROPILIN ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20220098312
- Publication date Mar 31, 2022
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220056096
- Publication date Feb 24, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210403524
- Publication date Dec 30, 2021
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODU...
- Publication number 20210393803
- Publication date Dec 23, 2021
- Trieza Therapeutics, Inc.
- Daniel HICKLIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-GITR ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20210269542
- Publication date Sep 2, 2021
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NOTCH3 ANTIBODIES
- Publication number 20210171627
- Publication date Jun 10, 2021
- AVEO Pharmaceuticals, Inc.
- Heidi Okamura
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210130430
- Publication date May 6, 2021
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20210115102
- Publication date Apr 22, 2021
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-GDF-15 ANTIBODIES
- Publication number 20210101968
- Publication date Apr 8, 2021
- AVEO PHARMACEUTICALS, INC.
- Lorena Lerner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ERBB3 ANTIBODIES
- Publication number 20200299406
- Publication date Sep 24, 2020
- AVEO PHARMACEUTICALS, INC.
- Sylvie Vincent
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283490
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283489
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY

William Winston

Person

Patents Grantslast 30 patents

Activatable cytokine polypeptides and methods of use thereof

Activatable cytokine polypeptides and methods of use thereof

Activatable interleukin-2 polypeptides and methods of use thereof

Separation moieties and methods of use thereof

Anti-GDF-15 antibodies

Anti-ErbB3 antibodies

Anti-TIGIT antigen-binding proteins and methods of uses thereof

Activatable interleukin-2 polypeptides and methods of use thereof

Activatable interleukin 12 polypeptides and methods of use thereof

Anti-TIGIT antigen-binding proteins and methods of use thereof

Activatable interleukin-2 polypeptides and methods of use thereof

Anti-neuropilin antigen-binding proteins and methods of use thereof

Anti-Notch3 antibody

Anti-GITR antigen-binding proteins and methods of use thereof

Anti-NOTCH3 antibodies

Activatable interleukin-2 polypeptides

Activatable interleukin 12 polypeptides

Anti-GDF15 antibodies

Anti-TIGIT antigen-binding proteins and methods of use thereof

Anti-ERBB3 antibodies

Immunomodulatory oncolytic adenoviral vectors, and methods of produ...

Anti-neuropilin antigen-binding proteins and methods of use thereof

Anti-Notch3 antibodies

Methods of treatment using anti-GDF15 antibodies

Anti-TIGIT antigen-binding proteins and methods of use thereof

Anti-ErbB3 antibodies

Anti-ErbB3 antibodies

Anti-GDF15 antibodies

Nucleic acid encoding hepatocyte growth factor (HGF) binding proteins

Anti-ron antibodies

Patents Applicationslast 30 patents

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

INDUCIBLE IL-2 AND PD-1/PD-L1 COMBINATION THERAPY

INDUCIBLE CYTOKINE PRODRUG AND PD-1/PD-L1 COMBINATION THERAPY

ACTIVATABLE INTERFERON POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ANTI-GDF-15 ANTIBODIES

ACTIVATABLE IL-12 POLYPEPTIDES AND METHODS OF USE THEREOF

Activatable Cytokine Polypeptides and Methods of Use Thereof

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ANTI-ERBB3 ANTIBODIES

SEPARATION MOIETIES AND METHODS OF USE THEREOF

MONOCLONAL ANTIBODIES TARGETING HSP70 AND THERAPEUTIC USES THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

ANTI-NOTCH3 ANTIBODY

SEPARATION MOIETIES AND METHODS OF USE THEREOF

ANTI-NEUROPILIN ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODU...

ANTI-GITR ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ANTI-NOTCH3 ANTIBODIES

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

SEPARATION MOIETIES AND METHODS OF USE THEREOF

ANTI-GDF-15 ANTIBODIES

ANTI-ERBB3 ANTIBODIES

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF